Molecular treatments to reduce catabolic effects in human meniscus explant models
Objectives: 1. To validate catabolic meniscus explant models induced by cytokines: interleukin-6 + interleukin-6 receptor + tumor necrosis factor alpha (IL6/TNF) and oncostatin M + tumor necrosis factor alpha (OSM/TNF). 2. To evaluate three potential anti-catabolic treatments: i) dexamethasone...
| Published in: | Osteoarthritis and Cartilage Open |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2665913125000548 |
